Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study

Overview of attention for article published in Gynecologic Oncology, May 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

blogs: 1 blog

twitter: 18 X users

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 21 X posts from 18 X users, with an upper bound of 90,164 followers.

Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study NRG-GOG-0182 https://t.co/GRsbNAgBhC @gynoncjnls

RT @TeamOvary_MSK: Fantastic work by @AaronPraissMD and @ROCearbhaill on reexamining the role of creatinine clearance in carboplatin dosing…

RT @ArturasDobilas: useful to know# Carboplatin dosing in the treatment of ovarian cancer: NRG oncology group study ⁦@OncoAlert⁩ ⁦@ESGO_soc…

RT @gynoncjnls: Carboplatin dosing 💉in the treatment of ovarian cancer: data do not support a min threshold CrCl <60 mL/min as exclusion cr…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 17 additional X posts.